BOTOX in the Treatment of Upper Facial Lines in Japan
Phase of Trial: Phase III
Latest Information Update: 23 May 2016
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Registrational; Therapeutic Use
- Sponsors Allergan
- 23 May 2016 Results published in Allergan media release.
- 01 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 26 May 2014 New trial record